Egyptian institution

The Egyptian International Pharmaceutical Industries Company (EIPICO) is the leading pharmaceutical manufacturer in Egypt and a major player in the Middle East and North Africa (MENA) region. Established in 1980, the company produces a vast portfolio of over 400 products across various therapeutic classes, including antibiotics, cardiovascular drugs, and ophthalmic preparations. EIPICO operates advanced manufacturing facilities that comply with international GMP standards and exports its products to more than 65 countries worldwide. The company is also expanding into the production of biosimilars and biological products through its EIPICO 3 project, aiming to localize the manufacturing of complex therapies in Egypt.